Abiopharma

MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

HealthStream Announces Share Repurchase Program

SenesTech Expands International Reach with the Addition of the Belize Raptor Center as an Official Distributor of Evolve® Rat Birth Control

Prothena - Prothena Highlights Phase 2 Data for Coramitug (Formerly PRX004) Published in Circulation, Official Journal of AHA

Precision Optics Announces Product Development Agreement to Develop Custom High-End Borescope for Jet Engines

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

Altimmune Announces Publication of IMPACT Phase 2b Trial Data in The Lancet and Concurrent Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2025

Allurion - Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing